AI Generated Image
Thousands of Bottles of Popular Blood Pressure Medication Recalled Nationwide
TODAY.com • • business
Key Points:
- Over 11,400 bottles of 25-mg chlorthalidone tablets, a popular blood pressure medication, have been voluntarily recalled nationwide due to a manufacturing issue causing the tablets to fail dissolution specifications, potentially reducing their effectiveness.
- The recall was initiated by Inventia Healthcare Limited, based in India, and distributed across the U.S. by Rising Pharma Holdings, Inc., with affected batches expiring in April 2027.
- The FDA classified the recall as a Class II moderate hazard, indicating the medication may cause temporary or medically reversible adverse health effects.
- Patients taking chlorthalidone are advised to check their medication labels for the specific batch numbers involved and consult their healthcare provider before making any changes to their prescription.
- This recall marks the second instance in less than a year involving commonly prescribed blood pressure medications, highlighting ongoing concerns about drug safety and manufacturing quality.
